Survival trends of gastrointestinal stromal tumor in real-world settings: a population-based retrospective study

PurposeThis study aims to evaluate whether survival outcomes for GIST patients have improved over the past decades and to identify the specific patient subgroups that have benefited from advances in treatment.Patients and methodsA total of 4,127 GIST patients diagnosed between January 1980, and Dece...

Full description

Saved in:
Bibliographic Details
Main Authors: Guohua Jia, Xiangpan Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-03-01
Series:Pathology and Oncology Research
Subjects:
Online Access:https://www.por-journal.com/articles/10.3389/pore.2025.1611896/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850233762396241920
author Guohua Jia
Xiangpan Li
author_facet Guohua Jia
Xiangpan Li
author_sort Guohua Jia
collection DOAJ
description PurposeThis study aims to evaluate whether survival outcomes for GIST patients have improved over the past decades and to identify the specific patient subgroups that have benefited from advances in treatment.Patients and methodsA total of 4,127 GIST patients diagnosed between January 1980, and December 2019, were included in this study using data from the Surveillance, Epidemiology, and End Results (SEER)-9 Registries. Survival differences among GIST patients were analyzed across five time periods (1980–1999, 2000–2004, 2005–2009, 2010–2014, and 2015–2019) and within demographic, neoplastic, temporal, economic, and geographic categories using the log-rank test. Multivariable Cox regression models were employed to identify risk factors associated with GIST-specific survival. Associations between time periods and GIST-specific mortality (TSM) were examined using a multivariable Cox regression model.ResultsSurvival outcomes for GIST patients significantly improved in the 2000–2009 period but showed no substantial improvement in the 2010–2019 period. After adjusting for age, gender, tumor location, ethnicity, tumor stage, median household income, and geographic area, the multivariable Cox regression models revealed that older age (≥65 years) (HR = 1.977, 95% CI = 1.470–2.657), tumors located outside the gastrointestinal tract (HR = 1.505, 95% CI = 1.267–1.786), regional lesions (HR = 2.225, 95% CI = 1.828–2.708), and distant lesions (HR = 5.177, 95% CI = 4.417–6.069) were independent risk factors for TSM (p < 0.05). After adjusting for time periods and age, gender, tumor location, tumor stage, median household income, patients in 2000–2004 (HR = 0.662, 95% CI = 0.523–0.839), 2005–2009 (HR = 0.431, 95% CI = 0.339–0.549), 2010–2014 (HR = 0.437, 95% CI = 0.341–0.561), and 2015–2019 (HR = 0.365, 95% CI = 0.273–0.489) had a significantly lower risk of TSM than patients in 1980–1999 (p < 0.05). Similarly, patients in 2005–2009 (HR = 0.661, 95% CI = 0.555–0.788), 2010–2014 (HR = 0.696, 95% CI = 0.578–0.838), and 2015–2019 (HR = 0.607, 95% CI = 0.476–0.773) also had a significantly lower risk of TSM than patients in 2000–2004 (p < 0.05). However, patients in 2010–2014 (HR = 1.042, 5% CI = 0.863–1.258) and 2015–2019 (HR = 0.945, 95% CI = 0.734–1.216) did not have a significantly lower risk of TSM compared to patients in 2005–2009 (p > 0.05).ConclusionGIST survival has significantly improved during the period 2000–2009 but showed no substantial improvement in 2010–2019, with the turning point for lower risk of TSM being 2005. Innovative strategies are needed to further improve survival outcomes for GIST patients, particularly for older patients and those with tumors originating outside the gastrointestinal tract.
format Article
id doaj-art-3ddf37a6698e43b5a0df88c91e04d87d
institution OA Journals
issn 1532-2807
language English
publishDate 2025-03-01
publisher Frontiers Media S.A.
record_format Article
series Pathology and Oncology Research
spelling doaj-art-3ddf37a6698e43b5a0df88c91e04d87d2025-08-20T02:02:51ZengFrontiers Media S.A.Pathology and Oncology Research1532-28072025-03-013110.3389/pore.2025.16118961611896Survival trends of gastrointestinal stromal tumor in real-world settings: a population-based retrospective studyGuohua Jia0Xiangpan Li1Cancer Center, Renmin Hospital of Wuhan University, Wuhan, Hubei, ChinaDepartment of Oncology, Renmin Hospital of Wuhan University, Wuhan, Hubei, ChinaPurposeThis study aims to evaluate whether survival outcomes for GIST patients have improved over the past decades and to identify the specific patient subgroups that have benefited from advances in treatment.Patients and methodsA total of 4,127 GIST patients diagnosed between January 1980, and December 2019, were included in this study using data from the Surveillance, Epidemiology, and End Results (SEER)-9 Registries. Survival differences among GIST patients were analyzed across five time periods (1980–1999, 2000–2004, 2005–2009, 2010–2014, and 2015–2019) and within demographic, neoplastic, temporal, economic, and geographic categories using the log-rank test. Multivariable Cox regression models were employed to identify risk factors associated with GIST-specific survival. Associations between time periods and GIST-specific mortality (TSM) were examined using a multivariable Cox regression model.ResultsSurvival outcomes for GIST patients significantly improved in the 2000–2009 period but showed no substantial improvement in the 2010–2019 period. After adjusting for age, gender, tumor location, ethnicity, tumor stage, median household income, and geographic area, the multivariable Cox regression models revealed that older age (≥65 years) (HR = 1.977, 95% CI = 1.470–2.657), tumors located outside the gastrointestinal tract (HR = 1.505, 95% CI = 1.267–1.786), regional lesions (HR = 2.225, 95% CI = 1.828–2.708), and distant lesions (HR = 5.177, 95% CI = 4.417–6.069) were independent risk factors for TSM (p < 0.05). After adjusting for time periods and age, gender, tumor location, tumor stage, median household income, patients in 2000–2004 (HR = 0.662, 95% CI = 0.523–0.839), 2005–2009 (HR = 0.431, 95% CI = 0.339–0.549), 2010–2014 (HR = 0.437, 95% CI = 0.341–0.561), and 2015–2019 (HR = 0.365, 95% CI = 0.273–0.489) had a significantly lower risk of TSM than patients in 1980–1999 (p < 0.05). Similarly, patients in 2005–2009 (HR = 0.661, 95% CI = 0.555–0.788), 2010–2014 (HR = 0.696, 95% CI = 0.578–0.838), and 2015–2019 (HR = 0.607, 95% CI = 0.476–0.773) also had a significantly lower risk of TSM than patients in 2000–2004 (p < 0.05). However, patients in 2010–2014 (HR = 1.042, 5% CI = 0.863–1.258) and 2015–2019 (HR = 0.945, 95% CI = 0.734–1.216) did not have a significantly lower risk of TSM compared to patients in 2005–2009 (p > 0.05).ConclusionGIST survival has significantly improved during the period 2000–2009 but showed no substantial improvement in 2010–2019, with the turning point for lower risk of TSM being 2005. Innovative strategies are needed to further improve survival outcomes for GIST patients, particularly for older patients and those with tumors originating outside the gastrointestinal tract.https://www.por-journal.com/articles/10.3389/pore.2025.1611896/fullGISTsurvivaltumor-specific mortalitytrendoutcome
spellingShingle Guohua Jia
Xiangpan Li
Survival trends of gastrointestinal stromal tumor in real-world settings: a population-based retrospective study
Pathology and Oncology Research
GIST
survival
tumor-specific mortality
trend
outcome
title Survival trends of gastrointestinal stromal tumor in real-world settings: a population-based retrospective study
title_full Survival trends of gastrointestinal stromal tumor in real-world settings: a population-based retrospective study
title_fullStr Survival trends of gastrointestinal stromal tumor in real-world settings: a population-based retrospective study
title_full_unstemmed Survival trends of gastrointestinal stromal tumor in real-world settings: a population-based retrospective study
title_short Survival trends of gastrointestinal stromal tumor in real-world settings: a population-based retrospective study
title_sort survival trends of gastrointestinal stromal tumor in real world settings a population based retrospective study
topic GIST
survival
tumor-specific mortality
trend
outcome
url https://www.por-journal.com/articles/10.3389/pore.2025.1611896/full
work_keys_str_mv AT guohuajia survivaltrendsofgastrointestinalstromaltumorinrealworldsettingsapopulationbasedretrospectivestudy
AT xiangpanli survivaltrendsofgastrointestinalstromaltumorinrealworldsettingsapopulationbasedretrospectivestudy